Showing results (141-150 of 273) with videos related to

Sort By:
Pageof 28
Disease Models & Mechanisms|May 5, 2011
Pathogen and host factors are needed to provoke a systemic host response to gastrointestinal infection of Drosophila larvae by Candida albicansMarcus T Glittenberg, Ilias Kounatidis, David Christensen, et al.
British Journal of Anaesthesia|March 23, 2020
Effect of tranexamic acid by baseline risk of death in acute bleeding patients: a meta-analysis of individual patient-level data from 28 333 patientsFrancois-Xavier Ageron, Angele Gayet-Ageron, Katharine Ker, et al.
BMJ (Clinical Research Ed.)|November 2, 2002
Incidence of fires and related injuries after giving out free smoke alarms: cluster randomised controlled trialCarolyn DiGuiseppi, Ian Roberts, Angie Wade, et al.
Wellcome Open Research|April 18, 2017
Statistical analysis plan for the WOMAN-ETAPlaT study: Effect of tranexamic acid on platelet function and thrombin generationKastriot Dallaku, Haleema Shakur, Phil Edwards, et al.
Trials|August 27, 2011
Between-centre differences and treatment effects in randomized controlled trials: a case study in traumatic brain injuryHester F Lingsma, Bob Roozenbeek, Pablo Perel, et al.
BMJ (Clinical Research Ed.)|November 2, 2002
Prevalence of working smoke alarms in local authority inner city housing: randomised controlled trialDiane Rowland, Carolyn DiGuiseppi, Ian Roberts, et al.
Genes, Chromosomes & Cancer|June 12, 2003
Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representationSusan M Gribble, Alistair G Reid, Ian Roberts, et al.
British Journal of Clinical Pharmacology|May 2, 2024
Population pharmacokinetic modelling and simulation of tranexamic acid in adult trauma patientsGideon Stitt, Philip C Spinella, Grant V Bochicchio, et al.
Trials|October 5, 2018
Outcome measures in clinical trials of treatments for acute severe haemorrhageAmy Brenner, Monica Arribas, Jack Cuzick, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2021
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteersZoe Kane, Roberto Picetti, Alison Wilby, et al.
Pageof 28